NCT05263947
- Conditions
- Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.
NCT05263947
NCT03724331
NCT06361121
NCT06000683
NCT06912113
NCT02513563
NCT04710628
NCT02523469
NCT03170206